Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]

Bibliographic Details
Main Authors: Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreira da Cunha, Caio Cesar de Melo Freire, Fábio Fernandes Neves, Lucimar Retto da Silva de Avó, Meliza Goi Roscani, Sigrid De Sousa dos Santos, Silvana Gama Florêncio Chach´
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Toxicology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750022000920
_version_ 1811188632065671168
author Henrique Pott-Junior
Mônica Maria Bastos Paoliello
Alice de Queiroz Constantino Miguel
Anderson Ferreira da Cunha
Caio Cesar de Melo Freire
Fábio Fernandes Neves
Lucimar Retto da Silva de Avó
Meliza Goi Roscani
Sigrid De Sousa dos Santos
Silvana Gama Florêncio Chach´
author_facet Henrique Pott-Junior
Mônica Maria Bastos Paoliello
Alice de Queiroz Constantino Miguel
Anderson Ferreira da Cunha
Caio Cesar de Melo Freire
Fábio Fernandes Neves
Lucimar Retto da Silva de Avó
Meliza Goi Roscani
Sigrid De Sousa dos Santos
Silvana Gama Florêncio Chach´
author_sort Henrique Pott-Junior
collection DOAJ
first_indexed 2024-04-11T14:23:15Z
format Article
id doaj.art-5264bc21037a4371a59109feac3fcc50
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-04-11T14:23:15Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-5264bc21037a4371a59109feac3fcc502022-12-22T04:19:00ZengElsevierToxicology Reports2214-75002022-01-0191023Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]Henrique Pott-Junior0Mônica Maria Bastos Paoliello1Alice de Queiroz Constantino Miguel2Anderson Ferreira da Cunha3Caio Cesar de Melo Freire4Fábio Fernandes Neves5Lucimar Retto da Silva de Avó6Meliza Goi Roscani7Sigrid De Sousa dos Santos8Silvana Gama Florêncio Chach´9Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil; Corresponding author.Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461 Bronx, NY, United StatesUniversity Hospital of the Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, BrazilDepartment of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazilhttp://www.sciencedirect.com/science/article/pii/S2214750022000920
spellingShingle Henrique Pott-Junior
Mônica Maria Bastos Paoliello
Alice de Queiroz Constantino Miguel
Anderson Ferreira da Cunha
Caio Cesar de Melo Freire
Fábio Fernandes Neves
Lucimar Retto da Silva de Avó
Meliza Goi Roscani
Sigrid De Sousa dos Santos
Silvana Gama Florêncio Chach´
Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
Toxicology Reports
title Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
title_full Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
title_fullStr Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
title_full_unstemmed Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
title_short Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
title_sort retraction notice to use of ivermectin in the treatment of covid 19 a pilot trial toxicol rep 8 2021 505 510
url http://www.sciencedirect.com/science/article/pii/S2214750022000920
work_keys_str_mv AT henriquepottjunior retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT monicamariabastospaoliello retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT alicedequeirozconstantinomiguel retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT andersonferreiradacunha retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT caiocesardemelofreire retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT fabiofernandesneves retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT lucimarrettodasilvadeavo retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT melizagoiroscani retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT sigriddesousadossantos retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510
AT silvanagamaflorenciochach retractionnoticetouseofivermectininthetreatmentofcovid19apilottrialtoxicolrep82021505510